Eventually every fund will do everything. DealBook reports on Citadel Investment Group’s foray into shareholder activism.

Signs that going private transactions are becoming more difficult to close. (via WSJ.com)

Jeffrey Ptak at Morningstar.com takes a closer look at the valuation behind the Blackstone Investment Group initial public offering.

With the rise of private equity, we should not be surprised that “secondary buyout funds” are on the rise as well. (via DealBook)

John Carney at DealBreaker.com has an in-depth look at the story behind the News Corp. (NWS) bid story.

Felix Salmon at Market Movers on the difference between a bull market and a bubble.

All About Alpha on the mechanics of implementing a 130/30 investment strategy.

FT Alphaville on the poor performance of UK-based REITs and their continued relative undervaluation.

Christopher Davis at Morningstar.com with a handful of Buffett-inspired mutual funds.

Bespoke Investment Group has an interesting post on high dividend ETFs.

Adam Warner at the Daily Options Report on how to play a retail stock scenario.

Eddy Elfenbein at Crossing Wall Street on the continued relative rise in cyclical stocks.

Christopher Sahl at TheStreet.com the dearth of closed-end funds trading at a discount.

CXO Advisory Group examines the value of yet another put-call measure.

Jeff Miller at A Dash of Insight on avoiding the “time frame mistake.”

Barry Ritholtz at the Big Picture on continued second-guessing of government economic statistics.

Brett Steenbarger at TraderFeed with five observations on what makes a “professional trader.”

Roger Ehrenberg at Information Arbitrage with advice on how to “stay current in a fast change world.”

Free exchange on the estate tax and the perpetuation of moneyed families.

Steven D. Levitt at the Freakonomics Blog on what economists think about prediction markets.

Mark Sappenfield at USA Today reports on “…jatropha – a plant many experts say is the most promising source for biodiesel.”

Thanks for checking in with Abnormal Returns where your feedback is always appreciated.